Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- BROKER RATINGS SUMMARY: Credit Suisse Raises Rio Tinto And Cuts BHP
7 Dec 2016 - LONDON MARKET OPEN: BT Down, Sky And TalkTalk Up On Openreach Decision
29 Nov 2016 - Countryside Properties posts rise in FY profit, revenue
29 Nov 2016 - UK Earnings, Trading Statements Calendar - Next 7 Days
22 Nov 2016 - LONDON MARKET CLOSE: Investors Take A Breath Before Fed Minutes
12 Oct 2016 - Countryside Properties sees 'significant' opportunity in partnerships
12 Oct 2016 - UK Earnings, Trading Statements Calendar - Next 7 Days
5 Oct 2016 - Broker tips: Persimmon, Restaurant Group, Cobham
15 Aug 2016
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties posts rise in FY profit, revenue
(ShareCast News) - Countryside Properties reported a rise in full-year pre-tax profit and revenue as it said 2016 was "another positive year" for the ...
Countryside Properties sees 'significant' opportunity in partnerships
(ShareCast News) - Private and public partnerships housebuilder Countryside Properties' rate of sales completions slowed but remained robust in the fo...
Broker tips: Persimmon, Restaurant Group, Cobham
(ShareCast News) - UK housebuilding shares have fallen 25% since Britain voted to leave the European Union and the sector has priced in a 5% drop in h...
Follow the stocks
